Clinical Research Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Cardiovasc Ther. 2021 May 3;2021:6667934. doi: 10.1155/2021/6667934. eCollection 2021.
It has been suggested that the a () gene rs4762 (p.Thr174Met) polymorphism might be associated with myocardial infarction (MI) risk, but the study results are still debatable. . In order to explore the relationship between p.Thr174Met polymorphism and MI risk, the current meta-analysis involving 7657 subjects from 11 individual studies was conducted.
A significant association between p.Thr174Met polymorphism and MI was found under recessive (OR: 2.26, 95% CI: 1.35-3.77, = 0.002), dominant (OR: 1.131, 95% CI: 1.016-1.260, = 0.024), codominant (OR: 2.198, 95% CI: 1.334-3.621, = 0.002), and additive (OR: 1.363, 95% CI: 1.132-1.641, = 0.001) genetic models. In the Asian subgroup, significantly increased MI risk was found under all genetic models ( < 0.05). No significant association between p.Thr174Met polymorphism and MI was found under all genetic models in the Caucasian subgroup ( > 0.05).
p.Thr174Met variant might increase MI risk, especially within the Asian population. The Met174 allele of p.Thr174Met might confer the risk for MI.
有人认为 a()基因 rs4762(p.Thr174Met)多态性可能与心肌梗死(MI)风险相关,但研究结果仍存在争议。为了探讨 p.Thr174Met 多态性与 MI 风险的关系,进行了本次包含 11 项独立研究的 7657 名受试者的荟萃分析。
在隐性遗传模型(OR:2.26,95%CI:1.35-3.77, = 0.002)、显性遗传模型(OR:1.131,95%CI:1.016-1.260, = 0.024)、共显性遗传模型(OR:2.198,95%CI:1.334-3.621, = 0.002)和加性遗传模型(OR:1.363,95%CI:1.132-1.641, = 0.001)中,p.Thr174Met 多态性与 MI 显著相关。在亚洲亚组中,所有遗传模型下 MI 风险均显著增加(<0.05)。在高加索亚组中,p.Thr174Met 多态性与 MI 之间无显著相关性(>0.05)。
p.Thr174Met 变体可能会增加 MI 风险,特别是在亚洲人群中。p.Thr174Met 多态性的 Met174 等位基因可能会增加 MI 的风险。